Executive Summary
This deobligations alert reveals $91.7B in stable, long-term federal contract obligations across 30 records, with 28 bullish signals dominated by DOE nuclear site management ($57B+ across Fluor/Savannah River, Argonne, Stanford, Hanford) and NASA space programs ($28B+ via Boeing ISS, SpaceX Crew, Jacobs/Syncom). Primes like Fluor, Boeing, and Jacobs benefit from low-risk cost-plus structures and 77%+ average outlay realization on executed portions, signaling revenue backlogs through 2026-2030. Investors should prioritize space/defense/energy sectors for portfolio stability amid fiscal 2026 recompete risks.
Tracking the trend? Catch up on the prior Contract Deobligations Alert digest from December 22, 2025.
Investment Signals(4)
- DOE Nuclear Management Locks In $57B Revenue Through 2026-2027(HIGH)▲
Fluor (Savannah River $25B), UChicago Argonne ($16.7B), Stanford ($14.5B), and Hanford ($1.1B) hold massive cost-plus contracts with $18.7B outlayed, providing decade-long stability.
- NASA Space Contracts Bolster Boeing, SpaceX, Jacobs with $28B Exposure(HIGH)▲
Boeing ISS ($22.3B to 2026), SpaceX Crew ($3B to 2030), and Jacobs/Syncom facilities ($1.2B to 2025) show $6.2B outlayed, underscoring entrenched positions.
- GSA IT/Engineering Awards Signal $5B+ Upside for Booz Allen, CACI, Peraton(MEDIUM)▲
Recent 2023-2024 awards (Booz Allen $2.6B pot., CACI $1.3B, Peraton $883M) under cost-plus terms offer multi-year growth to 2029.
- HHS Vaccine/IT Contracts Highlight McKesson $8B Potential(MEDIUM)▲
McKesson Specialty ($8.1B base+options, $153M obligated) and Noridian/Companion Data ($1.6B combined pot.) provide health admin stability to 2029.
Risk Flags(3)
- Competitive[HIGH RISK]▼
20+ contracts end 2026 (e.g., Savannah River, Boeing ISS, Argonne), risking recompetes and non-renewals.
- Execution[MEDIUM RISK]▼
Low outlays on $730M+ contracts (e.g., BL Harbert Beirut embassy $0 outlayed; Peraton $0) signal delays; subawards average 20%+ of value across 456+ recipients max.
- Market[MEDIUM RISK]▼
FFP structures (SpaceX $3B, McKesson $8B pot., Frequentis $145M) expose to cost overruns amid inflation.
Opportunities(3)
- ◆
$20B+ unexercised options (e.g., McKesson $8B, Booz Allen $2.2B, CACI $946M) across GSA/HHS contracts to 2029.
- ◆
Extensions on 15+ contracts (e.g., Noridian to 2028, SpaceX to 2030) tied to ongoing nuclear/space/health needs.
- ◆
Small/SDVOSB set-asides (Bluestag $649M pot., Aerodyne $531M, Frequentis $145M) position for non-competitive follow-ons.
Sector Themes(3)
- ◆
62% of value ($57B) in cost-plus M&O contracts for Savannah River/Argonne/Hanford through 2026-2027, with $19B outlayed.
- ◆
31% of value ($28B) across ISS/Crew/facilities ops to 2030, low-competition awards to Boeing/SpaceX/Jacobs.
- ◆
$6B+ potential in 2023-2024 awards (Booz/CACI/Peraton/GD) for engineering/IT to 2029.
Watch List(4)
- 👁
{"entity"=>"Fluor Corporation (Savannah River)", "reason"=>"$25B obligation (36% of period total) ends 2026; $9B outlayed signals scale.", "trigger"=>"Recompete award or extension announcement"}
- 👁
{"entity"=>"Boeing Company (ISS)", "reason"=>"$22B long-term NASA anchor amid commercial pressures.", "trigger"=>"Outlay acceleration >$500M/quarter"}
- 👁
{"entity"=>"McKesson Corporation", "reason"=>"$8.1B vaccine distro ceiling dwarfs $153M obligation; HHS recurring need.", "trigger"=>"Option exercise >$1B"}
- 👁
{"entity"=>"2026 DOE/NASA Recompetes", "reason"=>"15+ contracts (~$60B) expiring; winner-take-all dynamics.", "trigger"=>"RFI/RFP releases Q1 2026"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 30 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC